These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38427104)

  • 21. Fluorescence decay time distribution analysis of cyclic enkephalin analogues. Influence of the solvents and configuration of amino acids in position 2 and 3 on changes in conformation.
    Malicka J; Groth M; Czaplewski C; Liwo A; Wiczk W
    Acta Biochim Pol; 1999; 46(3):615-29. PubMed ID: 10698270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proton NMR conformational analysis of cyclic beta-casomorphin analogues of the type Tyr-cyclo[N omega-D-Orn-Xaa-Yaa-Gly-].
    Mrestani-Klaus C; Brandt W; Schmidt R; Neubert K; Schiller PW
    Arch Pharm (Weinheim); 1996 Mar; 329(3):133-42. PubMed ID: 9005812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enkephalin analogues containing beta-naphthylalanine at the fourth position.
    Mierke DF; Said-Nejad OE; Schiller PW; Goodman M
    Biopolymers; 1990 Jan; 29(1):179-96. PubMed ID: 2158358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, conformational studies, and molecular dynamics calculations of two cyclic tetrapeptides with 17- and 18-membered rings.
    Hölzemann G; Pachler KG; Eberhart B; Hölzel H; Kraft M; Barnickel G
    Int J Pept Protein Res; 1991 Apr; 37(4):283-92. PubMed ID: 1894444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel cyclic azo-bridged analogs of gonadotropin-releasing hormone.
    Fridkin G; Rahimipour S; Ben-Aroya N; Kapitkovsky A; Di-Segni S; Rosenberg M; Kustanovich I; Koch Y; Gilon C; Fridkin M
    J Pept Sci; 2006 Feb; 12(2):106-15. PubMed ID: 16059965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of conformation of the acyloxyalkoxy-based cyclic prodrugs of opioid peptides on their membrane permeability.
    Gudmundsson OS; Vander Velde DG; Jois SD; Bak A; Siahaan TJ; Borchardt RT
    J Pept Res; 1999 Apr; 53(4):403-13. PubMed ID: 10406218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conformation-activity relationships of cyclo-constrained micro/delta opioid agonists derived from the N-terminal tetrapeptide segment of dermorphin/deltorphin.
    Rodziewicz-Motowidło S; Czaplewski C; Luczak S; Ciarkowski J
    J Pept Sci; 2008 Aug; 14(8):898-902. PubMed ID: 18338322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Highly potent side-chain to side-chain cyclized enkephalin analogues containing a carbonyl bridge: synthesis, biology and conformation.
    Pawlak D; Oleszczuk M; Wójcik J; Pachulska M; Chung NN; Schiller PW; Izdebski J
    J Pept Sci; 2001 Mar; 7(3):128-40. PubMed ID: 11297348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NMR study of cyclic peptides with renin inhibitor activity.
    Sarma AV; Ramana Rao MH; Sarma JA; Nagaraj R; Dutta AS; Kunwar AC
    J Biochem Biophys Methods; 2002 Mar; 51(1):27-45. PubMed ID: 11879917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclic enkephalin and dermorphin analogues containing a carbonyl bridge.
    Filip K; Oleszczuk M; Wójcik J; Chung NN; Schiller PW; Pawlak D; Zieleniak A; Parcińska A; Witkowska E; Izdebski J
    J Pept Sci; 2005 Jun; 11(6):347-52. PubMed ID: 15635652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced peptide bond cyclic somatostatin based opioid octapeptides. Synthesis, conformational properties and pharmacological characterization.
    Kazmierski WM; Ferguson RD; Knapp RJ; Lui GK; Yamamura HI; Hruby VJ
    Int J Pept Protein Res; 1992 May; 39(5):401-14. PubMed ID: 1358847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclic pentapeptide analogs based on endomorphin-2 structure: cyclization studies using liquid chromatography combined with on-line mass spectrometry and tandem mass spectrometry.
    Piekielna J; Kluczyk A; Perlikowska R; Janecka A
    Peptides; 2014 May; 55():32-40. PubMed ID: 24525024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined use of NMR, distance geometry and MD calculations for the conformational analysis of opioid peptides of the type [D(L)-Cys2, D(L)-Cys5]enkephalin.
    Kolp B; Andreae F; Fabian WM; Sterk H
    Int J Pept Protein Res; 1996 Nov; 48(5):443-51. PubMed ID: 8956077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformational analysis of cyclic partially modified retro-inverso enkephalin analogues by proton NMR.
    Mammi NJ; Goodman M
    Biochemistry; 1986 Nov; 25(23):7607-14. PubMed ID: 3801437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conformational analysis of two cyclic analogs of angiotensin: implications for the biologically active conformation.
    Nikiforovich GV; Kao JL; Plucinska K; Zhang WJ; Marshall GR
    Biochemistry; 1994 Mar; 33(12):3591-8. PubMed ID: 8142357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A cyclic enkephalin analog with high in vitro opiate activity.
    DiMaio J; Schiller PW
    Proc Natl Acad Sci U S A; 1980 Dec; 77(12):7162-6. PubMed ID: 6261242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclic enkephalin-deltorphin hybrids containing a carbonyl bridge: structure and opioid activity.
    Ciszewska M; Ruszczyńska K; Oleszczuk M; Chung NN; Witkowska E; Schiller PW; Wójcik J; Izdebski J
    Acta Biochim Pol; 2011; 58(2):225-30. PubMed ID: 21584287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclic side-chain-linked opioid analogs utilizing cis- and trans-4-aminocyclohexyl-D-alanine.
    Piekielna J; Gentilucci L; De Marco R; Perlikowska R; Adamska A; Olczak J; Mazur M; Artali R; Modranka J; Janecki T; Tömböly C; Janecka A
    Bioorg Med Chem; 2014 Dec; 22(23):6545-6551. PubMed ID: 25456075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conformational analysis of mu-selective [D-Ala2,MePhe4]enkephalins.
    Penkler LJ; Van Rooyen PH; Wessels PL
    Int J Pept Protein Res; 1993 Mar; 41(3):261-74. PubMed ID: 8385078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the bioactive form and molecular determinants of recognition of cyclic enkephalin peptides at the delta-opioid receptor.
    Chew C; Villar HO; Loew GH
    Biopolymers; 1993 Apr; 33(4):647-57. PubMed ID: 8385507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.